Aditxt (ADTX) News Today $0.32 -0.02 (-5.08%) (As of 12:30 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Aditxt, Inc. (NASDAQ:ADTX) Sees Significant Increase in Short InterestNovember 15, 2024 | americanbankingnews.comAppili Therapeutics shareholders vote in favor of Aditxt transactionNovember 14, 2024 | markets.businessinsider.comEvofem Biosciences Announces Financial Results for the Third Quarter of 2024November 14, 2024 | prnewswire.comAditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of SharesNovember 8, 2024 | finance.yahoo.comAditxt, Inc. Focuses on Growth Amid Nasdaq ComplianceNovember 6, 2024 | markets.businessinsider.comAditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary AdifemNovember 6, 2024 | businesswire.comEvofem Secures Investor Support for Proposed Merger through Voting AgreementsNovember 6, 2024 | prnewswire.comAditxt (NASDAQ:ADTX) Stock, Earnings Estimates, EPS, And RevenueOctober 16, 2024 | benzinga.comAditxt CEO Clarifies NASDAQ Compliance and Capital StrategyOctober 13, 2024 | finance.yahoo.comAditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight TimeOctober 9, 2024 | businesswire.comAditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With EvofemOctober 8, 2024 | finance.yahoo.comAditxt gears up for strategic acquisitions and Nasdaq complianceOctober 6, 2024 | uk.investing.comAditx Therapeutics Inc (ADTX)September 29, 2024 | investing.comAmazon staff threaten mass exodus following WFH banSeptember 27, 2024 | au.finance.yahoo.comAditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024September 27, 2024 | businesswire.comAditxt's Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025September 20, 2024 | businesswire.comAppili Therapeutics Inc.: Appili Therapeutics Announces Results of Annual and Special Meeting of ShareholdersSeptember 18, 2024 | finanznachrichten.deInvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Seeks Grant Funding to Advance Early Detection, Management of Prostate CancerSeptember 5, 2024 | msn.comInvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Announces Participation at H.C. Wainwright 26th Annual Global Investment ConferenceAugust 29, 2024 | msn.comAditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024August 29, 2024 | businesswire.comEvofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral SolutionAugust 20, 2024 | prnewswire.comBioMedNewsBreaks — Evofem Biosciences Inc. (EVFM) Releases Second-Quarter 2024 Financial Results, Company UpdateAugust 14, 2024 | msn.comAditxt shareholders approve strategic proposalsAugust 14, 2024 | investing.comAditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders' Meeting, Setting the Stage for 2024 and 2025 Strategic PlansAugust 14, 2024 | stockhouse.comEvofem Biosciences Announces Financial Results for the Second Quarter of 2024August 14, 2024 | prnewswire.comAditxt swaps pre-funded warrants for preferred stock and new warrantsAugust 10, 2024 | uk.investing.comAditxt Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesAugust 9, 2024 | businesswire.comAditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesAugust 9, 2024 | businesswire.comAditxt Subsidiary Pearsanta Seeks Clinical Trial Translational Endpoints Research Award for Early Detection of Ovarian CancerAugust 7, 2024 | stockhouse.comBiotech Soars Despite Broader SelloffAugust 7, 2024 | msn.comFCA makes first crypto-related sting against Coinbase subsidiaryJuly 25, 2024 | uk.finance.yahoo.comEvofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1stJuly 25, 2024 | globenewswire.comEvofem Signs Phexxi® License Agreement for Middle East with Pharma 1July 23, 2024 | prnewswire.comWhat's Going On With Aditxt Shares Wednesday?July 19, 2024 | msn.comWhy Is Aditxt (ADTX) Stock Up 72% Today!July 17, 2024 | investorplace.comLupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSECJuly 15, 2024 | prnewswire.comHello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's HealthcareJune 27, 2024 | prnewswire.comEvofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of MatterJune 11, 2024 | prnewswire.comEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the First Quarter of 2024May 15, 2024 | finanznachrichten.deEvofem Biosciences Announces Financial Results for the First Quarter of 2024May 15, 2024 | prnewswire.comAditxt secures $4.2 million in private placementMay 5, 2024 | investing.comCORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesMay 3, 2024 | finance.yahoo.comAditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesMay 3, 2024 | businesswire.comAditxt to Buy Biopharmaceutical Company Appili Therapeutics for Undisclosed AmountApril 2, 2024 | marketwatch.comAppili Therapeutics To Be Acquired By AditxtApril 2, 2024 | markets.businessinsider.comTrading was temporarily halted for "ADTX" at 09:04 AM with a stated reason of "LULD pause."April 2, 2024 | marketbeat.comAditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)April 2, 2024 | businesswire.comEvofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023March 27, 2024 | finanznachrichten.deEvofem Reports $18.2 million of Phexxi Net Product Sales in 2023March 27, 2024 | prnewswire.comEvofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-CalMarch 20, 2024 | prnewswire.com Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. ADTX Media Mentions By Week ADTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADTX News Sentiment▼0.610.47▲Average Medical News Sentiment ADTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADTX Articles This Week▼31▲ADTX Articles Average Week Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biomerica News Aeterna Zentaris News Aptevo Therapeutics News Organovo News Alzamend Neuro News Upexi News Hepion Pharmaceuticals News Bionomics News Portage Biotech News Orgenesis News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
